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An Induced Ets Repressor Complex
Regulates Growth Arrest
during Terminal Macrophage Differentiation
activity (O’Neill et al., 1994; Rebay and Rubin, 1995).
This causes a Ras-dependent switch of activated PNT-
P2 for Yan at Ets sites in the promoters of target genes,
such as phyllopod, that positively regulate photorecep-
tor differentiation.
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its direct interaction with DP103, a protein recently iden- myelocytic cell line that further differentiates into granulo-
cytes or macrophages when treated with the granulocytetified to interact with the transforming Epstein-Barr nu-
clear antigens (EBNAs) 2 and 3c (Grundhoff et al., 1999). colony stimulating factor (G-CSF) or M-CSF, respectively
(Calvo et al., 2000; Figure 2A). In these cells, M-CSFIntriguingly, members of the pRb family proteins are also
required for METS-mediated growth arrest, suggesting induced expression of METS together with that of Ets2,
c-Fos, and SR-A. In contrast, expression of the cell cy-a combinatorial mechanism by which permanent exit
from the cell cycle can be achieved. cle-regulatory genes c-Myb and c-Myc was suppressed
(Figure 2A).
Results
METS Selectively Represses Cell Cycle Control
Genes and Blocks ProliferationMETS Is an Ets Repressor that Is Induced
during Macrophage Differentiation Based on the coordinate upregulation of METS and down-
regulation of c-Myb and c-Myc during macrophage dif-To identify members of the Ets family that might potentially
play roles in the coordination of myeloid proliferation and ferentiation and previous studies indicating that c-Myb
and c-Myc are targets of positive Ets factors (Rousselmaturation, we applied a degenerate PCR approach to
amplify the DNA binding domains (DBDs) of Ets family et al., 1994; Sullivan et al., 1997), we evaluated the possi-
bility that they might represent direct target genes ofmembers in THP-1 monocytic leukemia cells that had
been treated with the phorbol ester TPA to induce mac- METS. Consistent with this, forced expression of METS
repressed c-Myb and c-Myc promoter activity (Figurerophage differentiation. These studies identified an Ets
family member that was markedly upregulated in TPA- 2B). Evaluation of other promoters directing the expres-
sion of cell cycle control genes indicated that that thetreated cells. By subsequently screening a murine mac-
rophage cDNA library with the PCR product as the Cdc2 promoter was also strongly repressed by METS
(Figure 2B). In contrast, METS had relatively little effectprobe, we obtained two independent clones encoding
a 513 amino acid protein. Because this protein blocks on the activities of the SR-A, Gelatinase B, or Macrosialin
promoters (Figure 2B), which are activated by AP-1/Etsmitogenic responses mediated by Ets factors such as
Ets2, we refer to it as mitogenic Ets transcriptional sup- ternary complexes in response to Ras signaling (Guidez
et al., 1998; Li et al., 1998; Saarialho-Kere et al., 1993).pressor (METS). It is highly related to Ets2 repressor
factor (ERF) (Sgouras et al., 1995) throughout the Ets Although the repression function of the related Ets re-
pressor ERF has been demonstrated to be inactivatedDNA binding domain, the adjacent conserved region 1
(CR1), and three additional regions, identified as CR2, by Ras signaling (Sgouras et al., 1995), GAL4-METS
retained repressor activity in cells expressing a constitu-CR3, and CR4, and is identical to mPE1 reported in
murine osteoblasts while this work was in progress (Bid- tively active Val12-Ras mutant and in cells stimulated
with phorbol 12-myristate 13-acetate (PMA; Figure 2C).der et al., 2000; Figure 1A). Electrophoretic mobility shift
assays using competitor oligonucleotides indicated that These observations raised the possibility that METS
might negatively regulate myeloid proliferation. To testMETS bound with high affinity to a consensus DNA site
recognized by Ets2, but not to the Ets site contained this hypothesis, MSCV retroviral vectors were generated
directing expression of green fluorescent protein (GFP)within the serum response element (SRE) of the c-Fos
promoter (Figure 1B). When expressed in CV1 cells, and either wild-type METS or a fusion protein of the
METS DBD linked to the transactivation domain of VP16METS strongly inhibited the activity of the thymidine
kinase (TK) promoter when linked to the consensus Ets2 that does not repress transcription. A downstream inter-
nal ribosomal binding site was used for initiation of GFPsite, but did not inhibit the TK promoter itself or the
-actin promoter (Figure 1C). Fusion of C-terminal frag- translation (Figure 2D). Following infection, ECoM1-G
cells, which are promyelocytic cells that are transformedments of METS to the DNA binding domain of GAL4
revealed the presence of two independent repression do- with a conditional E2A-Pbx1 fusion protein (Sykes and
Kamps, 2001), GFP expression was used to select cellsmains, referred to as RD-N and RD-C (Figures 1A and 1D).
RNase protection assays failed to detect METS mRNA by FACS for further analysis. Cells infected with the
control MSCV-GFP vector lacking METS, or the MSCVin freshly isolated immature bone marrow progenitor
cells (Figure 1E). However, treatment of these cells with vector directing expression of an activating form of
METS (VP-16-METS), proliferated equivalently in GM-macrophage colony stimulating factor (M-CSF) to in-
duce differentiation of adherent macrophages resulted CSF-containing growth media, while cells infected with
MSCV-METS remained viable but did not proliferatein a marked upregulation of METS mRNA. Western blot-
ting experiments detected low levels of METS protein (Figure 2D).
To further examine the ability of METS to block growthup to day 4 of M-CSF-dependent differentiation, with a
marked increase in expression observed by day 7 of factor-dependent proliferation, calibrated amounts of
GST-METS fusion proteins were microinjected into theculture (Figure 1F). High levels of METS mRNA and pro-
tein were also observed in elicited peritoneal macro- nuclei of Rat 1 cells treated with epidermal growth factor
(EGF), which stimulates DNA synthesis and cell divisionphages that are terminally differentiated (Figures 1E and
1F). Quantification of METS protein levels in elicited peri- in a Ras-dependent manner (Stacey et al., 1988). GST-
METS potently inhibited EGF-dependent incorporationtoneal macrophages indicated more than 80,000 mole-
cules per cell, while terminally differentiated bone marrow- of BrdU, with half-maximal inhibition observed with in-
jection of approximately 7500 molecules of METS pro-derived macrophages expressed greater than 600,000
molecules of METS protein per cell. A similar pattern tein per cell (Figures 2E and 2F). Rat 1 cells were also
infected with either the control MSCV-GFP retroviralevolved in Hoxa9 HF-1 cells, a Hoxa9-immortalized pro-
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Figure 1. METS Is a Transcriptional Repressor that Is Upregulated during Terminal Macrophage Differentiation
(A) Sequence alignment between METS and ERF. The bar graphs show percent homologies between the conserved regions (CR) of METS
and ERF and indicate the N-terminal repressor domain (RD-N) and C-terminal repressor domain (RD-C).
(B) Binding of recombinant GST-METS to a 32P-labeled probe corresponding to a consensus Ets2 recognition element and competition by
unlabeled oligonucleotides containing the c-fos promoter serum response element (SRE) or a consensus Ets2 site. The numbers on top of
the panel indicate the ratio of unlabeled competitor oligonucleotides to labeled probe.
(C) Transient transfection of METS into CV-1 cells represses transcription from the TK promoter when linked to the Ets2 consensus site, but
not the TK promoter itself. Basal promoter activities were as follows: -actin; 220 relative light unit (RLU)/U -gal activity, TK promoter; 14
RLU/U -gal, Ets-TK promoter · 82 RLU/U -gal.
(D) METS contains two transferable repressor domains. The indicated regions of METS were linked to the DNA binding domain of GAL4 and
tested for their ability to repress activity of a TK promoter under control of five repeats of the GAL1 upstream activating sequence (GAL UAS)
in CV-1 cells.
(E) RNase protection assay demonstrating high expression of METS mRNA in peritoneal macrophages (perit. mφ) and its upregulation in bone
marrow progenitor cells (b.m. prog.) induced to differentiate into macrophages by treatment with M-CSF for 1 to 5 days.
(F) Western blotting of METS protein in peritoneal macrophages and bone marrow progenitor cells induced to differentiate into macrophages
by 2 to 9 days of M-CSF treatment. (Asterisks denote METS degradation products.)
vector or the MSCV-METS-GFP vector, and the infected the Ets DNA binding domain (Figure 3A). Evaluation of
the c-Myc promoter sequence revealed the presence ofpopulations of cells were sorted based on GFP expres-
sion 72 hr later. The GFP-positive cells infected with multiple potential binding sites containing the core Ets
recognition sequence GGAA. Double-stranded oligonu-the MSCV-METS-GFP vector expressed METS at levels
comparable to primary macrophages and exhibited cleotides corresponding to each of these sites were
tested for their ability to compete for the binding of full-markedly reduced expression of endogenous c-Myc
protein compared to GFP-negative cells or GFP-positive length METS to the radiolabeled consensus Ets2 site in
electrophoretic mobility shift assays (EMSAs). A repre-cells infected with control virus (Figure 2G). Intriguingly,
recombinant METS truncated at amino acid 332 was as sentative experiment is illustrated in Figure 3B. Several
high-affinity binding sites were identified by this ap-effective as the full-length protein (Figure 2E). In con-
trast, the DBD tethered to C-terminal residues 391–513 proach, including sites at 350, –153, 336, –853, and
1153, with respect to the upstream promoter P1. A com-(GST-METSNRD) did not block EGF-mediated cell pro-
liferation. Likewise, a deletion mutant lacking the Ets posite site previously found to bind both E2F proteins
and Ets2 (Myc E2F/Ets2; Roussel et al., 1994) was notdomain residues 1–131 (GST-METSDBD) and a short
splicing variant found to be expressed in a human ade- required for METS-mediated repression of the c-Myc
promoter because repression was still observed whennocarcinoma (METS1–143) did not inhibit BrdU incorpora-
tion. Together, these experiments indicated that METS this site was mutated (Figure 3A). By arranging these
binding sites in order of decreasing affinity, a markedexerted antiproliferative effects through the N-terminal
repression domain and that the intact DBD was required preference for G/A at position 5 and T/G at position 6
of the highest affinity binding sites was observed,for this function.
To begin to investigate the mechanisms responsible whereas no clear sequence specificity was discernable
upstream of position 1 (Figure 3C). The sequence re-for repression of a subset of Ets target genes by METS,
the c-Myc promoter was subjected to further analysis. quirements at positions 4 and 5 for high-affinity binding
were confirmed by a systematic analysis of oligonucleo-Repression of the c-Myc promoter by METS required
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Figure 2. METS Represses Cell Cycle Control Genes and Inhibits Growth Factor-Dependent DNA Synthesis
(A) Northern blot analysis of mRNA derived from Hoxa9-immortalized bone marrow-derived cells in the progenitor stage and after granulocyte
differentiation stimulated by G-CSF or macrophage differentiation stimulated by M-CSF.
(B) Forced expression of METS results in significant repression of the c-Myc, c-Myb, and Cdc2 promoters, but not the SR-A, Gelatinase B,
or Macrosialin promoters.
(C) Gal-METS132–513 retains repressor activity in CV-1 cells transfected with Val12Ras or treated with PMA.
(D) Retroviral expression of METS blocks proliferation of E2A-Pbx1-transformed myeloid progenitor cells in response to GM-CSF.
(E) Antiproliferative effects of METS require the N-terminal repression domain. Cells were microinjected with GST or the indicated GST-METS
fusion proteins. The upper panels indicate representative fields showing, from left to right, GST control, GST-METS (aa 1–513), GST-METSDBD
(aa 131–486), and GST-METSNRD (aa 1–115 plus 391–513). Injected cells appear green; cells with incorporated BrdU are red. Injected cells
demonstrating BrdU incorporation are indicated by arrows and have a yellow nucleus. Quantification of the percent of injected cells incorporating
BrdU is indicated in the lower panel.
(F) Microinjection of physiologic levels of METS block EGF-dependent DNA synthesis in Rat 1 cells. Cells were microinjected with the indicated
amounts of GST-METS protein (molecules/cell), treated with EGF, and scored for incorporation of BrdU.
(G) Expression of METS in Rat1 cells inhibits endogenous c-Myc expression. Cells were infected with the control or METS retroviral vectors
described in (D). GFP and GFP cells were sorted, and 106 cells were analyzed by Western blotting for METS and c-Myc expression 72 hr
later. METS expression in 106 bone marrow-derived Mφ is shown for comparison.
tides containing all possible base pair combinations in- of GGAA(G/A)(T/G), we searched sequence databases
for these sites in other promoters. Potential METS sitestroduced into the context of the Myc-153 sequence (data
not shown). The consensus METS DNA binding site de- were identified in several additional cell cycle control
genes, including Cdc2 and the p54 subunit of DNA pri-fined by these experiments is nearly identical to the
consensus binding sites previously determined for the mase. Intriguingly, in each case at least one METS site
could be identified within 150 bp of an E2F binding site.Ets activators Ets1, Ets2, and PEA3 (Graves and Pet-
ersen, 1998). However, in contrast to the Ras-response To determine whether METS discriminated between
monomeric binding sites present in cell cycle-regulatoryelements recognized by Ets1, Ets2, and PEA3 in cell
type-specific genes such as SR-A, which consist of AP- genes such as c-Myc, Cdc2, and the p54 subunit of
DNA primase versus composite elements in cell type-1/Ets composite elements, none of the high-affinity
METS binding sites in the c-Myc promoter contained specific genes such as SR-A in cells, chromatin immuno-
precipitation (ChIP) experiments were performed. Spe-adjacent AP-1 recognition motifs. Thus, these sites ap-
pear to represent recognition elements for Ets mono- cific primers were designed to amplify promoter regions
containing putative Ets and E2F binding sites in eachmers. Using the consensus recognition site for METS
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173
Figure 3. METS Discriminates between
Monomeric and Composite Ets Binding Sites
in Cell Cycle-Regulatory and Cell Type-Spe-
cific Promoters
(A) METS represses the c-Myc promoter in
a DNA binding domain-dependent manner.
CV-1 cells were transfected with a c-Myc pro-
moter-luciferase reporter gene or a c-Myc
promoter containing a mutation in the com-
posite E2F/Ets2 element (Myc-mut E2F/Ets2).
Cells were cotransfected with a CMV vector
directing the expression of wild-type METS
or METS132-513 lacking the Ets DNA binding
domain.
(B) METS binds to a subset of Ets recognition
elements with high affinity. Full-length METS
was incubated with a 32P-labeled DNA probe
containing an Ets2 consensus recognition
site, and protein/DNA complexes were re-
solved by an electrophoretic mobility shift
assay. Relative binding to other DNA se-
quences was assessed by competition with
a 100-fold excess of the indicated, unlabeled
oligonucleotides.
(C) Alignment and relative binding affinities
of METS for potential Ets binding sites within
the c-Myc promoter.
(D) ChIP assays in terminally differentiated
mouse peritoneal macrophages. Following
formaldehyde crosslinking, genomic se-
quences corresponding to c-Myc 114/
215, the p54 subunit of DNA primase 213/
66, and SR-A 486/96 regions were subjected to PCR amplification following immunoprecipitation of protein-DNA products with the
antibodies listed on top of each panel.
(E) ChIP assays for the c-Myc and p54 subunit of DNA primase—promoters in EcoM1-M cells representing a mixed population of proliferating
promyelocytes and differentiated F4/80-positive macrophages.
(F) ChIP assays for the c-Myc and p54 subunit of DNA primase promoters in primary bone marrow progenitor cells.
(G) ChIP assays in terminally differentiated macrophages after primary immunoprecipitation with anti-METS IgG. In the second round, the
antibodies listed at the top of the panel were used followed by PCR amplification of c-Myc 114/215.
promoter (see Experimental Procedures). In addition, represent a mixed population in which the majority of
cells proliferate continuously in the presence of GM-primers were designed to amplify a 3 coding region of
the c-Myc gene, which served as a negative control. CSF as undifferentiated promyelocytes, with 20%–30%
of the cells undergoing spontaneous differentiation toChIP experiments were initially carried out in thioglyco-
late-elicited mouse peritoneal macrophages, which are F4/80-positive macrophages. Anti-E2F4 IgG was more
effective than anti-E2F1 IgG in enriching the c-Myc andterminally differentiated and express high levels of SR-A
but virtually no c-Myc (Guidez et al., 1998). Specific p54 promoters from terminally differentiated macro-
phages (Figure 3D), while the converse pattern was ob-anti-METS IgG, but not anti-Ets1/2 IgG, was able to
immunoprecipitate the c-Myc promoter region from ter- served in EcoM1-M cells and proliferating bone marrow
progenitor cells (Figures 3E and 3F). Similar results wereminally differentiated macrophages (Figure 3D). In con-
trast, the anti-Ets1/2 IgG, but not the anti-METS IgG, obtained for the Cdc2 promoter (data not shown and
Figure 6E). In contrast to the results obtained in termi-was capable of precipitating the SR-A promoter from
the same population of sheared DNA fragments (Figure nally differentiated macrophages, the anti-Ets1/2 anti-
body was capable of precipitating the c-Myc and p543D). No enrichment of the 3 region of the c-Myc gene
was observed with either antibody, demonstrating the promoters from both of these proliferating populations
of cells (Figures 3E and 3F). These findings are consis-specific nature of protein/promoter DNA interactions
(data not shown and Figure 6E). These experiments indi- tent with previous studies reporting that Ets2 activates
the c-Myc promoter in proliferating cells (Langer et al.,cated that METS binds to Ets recognition elements in
the c-Myc gene, but not to the composite AP-1/Ets site 1992; Roussel et al., 1994) and suggest that Ets2 may
also play roles in activation of other genes required forin the SR-A gene. In contrast, Ets2, and perhaps other
Ets activators, remain bound to composite AP-1/Ets proliferation, such as p54 and Cdc2.
To determine whether METS and E2F4 bind simultane-sites in terminally differentiated macrophages despite
high levels of METS expression (Figure 3D). ChIP experi- ously to the c-Myc promoter, ChIP experiments were
performed in which sheared DNA was first immunopre-ments were also used to evaluate the relative binding
of METS, Ets1/2, and E2F transcription factors to the cipitated with anti-METS IgG and then subjected to a
second round of immunoprecipitation with anti-E2F4 IgGc-Myc and p54 promoters in terminally differentiated
macrophages, EcoM1-M cells, and proliferating bone (Figure 3G). These experiments indicated that E2F4 and
METS were bound to the same region of the c-Mycmarrow progenitor cells (Figures 3D–3F). EcoM1-M cells
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Figure 4. DP103 Interacts with METS and Is
Required for RD-N Repression Activity
(A) Schematic representation of DP103 and
, indicating conserved domains. Y123 repre-
sents one of the initial METS-interacting
clones obtained by two-hybrid screening and
was used for quantitative interaction assays
with the indicated Gal4-METS fusion pro-
teins. The vertical line indicates the back-
ground activity of the GAL1-lacZ reporter
gene.
(B) Interaction of 35S-labeled DP103-414-824
with GST alone and GST fused to N- and
C-terminal fragments of METS.
(C) Comparison of METS and DP103 expres-
sion patterns in whole-body sections of
mouse embryos at E13.5.
(D) Western blot indicating coimmunoprecipi-
tation of METS from whole-cell lysates of
E2A-Pbx1-immortalized bone marrow pre-
cursors immunoprecipitated with anti-DP103
antiserum.
(E) DP103 is required for repression by RD-
N of METS. A 3x-UAS-TK-lacZ reporter was
injected into the nuclei of Rat 1 cells along
with the indicated antibodies and plasmids
directing expression of the GAL4 DNA bind-
ing domain, GAL4-METS-RD-N, or GAL4-
METS-RD-C. Promoter activity was quanti-
fied by the percentage of injected cells that
stained blue (X-gal staining).
promoter. In contrast, anti-RNA polymerase II IgG failed quence analysis of full-length clones obtained by sec-
to precipitate the c-Myc promoter following initial pre- ondary screening of a human liver cDNA  phage library
cipitation with anti-METS IgG, consistent with the role revealed the encoded protein to be a member of the
of METS as a transcriptional repressor. DEAD box family of RNA helicases independently iso-
The ability of METS to repress transcription in tran- lated as DP103/Gemin3 (Charroux et al., 1999; Grund-
sient transfection assays was sensitive to trichostatin A hoff et al., 1999), hereafter referred to as DP103. Murine
(TSA), suggesting the involvement of histone deacety- cDNAs and a previously unknown shorter splicing vari-
lases (HDACs; data not shown). ChIP experiments were ant that we refer to as DP103were obtained by analyz-
therefore carried out to determine whether specific ing expressed sequence tag (EST) clones of the IMAGE
HDACs were associated with c-Myc promoter se- project. As shown in Figure 4A, the N-terminal half of
quences occupied by METS in terminally differentiated DP103 contains eight conserved regions for ATP bind-
macrophages. Following initial immunoprecipitation ing and hydrolysis, helicase activity, and RNA binding.
with anti-METS IgG, the c-Myc promoter region could be In contrast, the C-terminal stretch of DP103 (amino
secondarily immunoprecipitated with anti-HDAC2 and acids 400–834) is unique to this molecule with the excep-
anti-HDAC5 IgGs, but not HDAC1, HDAC3, or HDAC6 tion of amino acids 599–611 that can also be found in
IgGs (Figure 3G). Experiments testing the ability of METS two other human DEAD box genes, i.e., RCK and the
to directly interact with HDAC2 and HDAC5 in vitro re- nuclear RNA helicase U90426. At its very C-terminal end,
vealed little or no binding (data not shown), raising the DP103 harbors the motif WYDCHRE found in Gli proteins
possibility that they were recruited to the c-Myc pro- and the SANT domain of N-CoR (Aasland et al., 1996).
moter through an intermediary factor. In situ hybridization analysis of METS and DP103 mRNA
in mouse embryos indicated coexpression in several
tissues, including midbrain, Rathke’s pouch, thymus,Identification of DP103 as a Corepressor of METS
and skin (Figure 4C). DP103 was also expressed in E2A-To identify potential intermediary factors that might as-
Pbx1-immortalized myeloid progenitor cells in whichsemble a histone deacetylase complex at the N-terminal
METS expression is induced during differentiation. METSrepression domain of METS and also mediate its antipro-
and DP103 could be coimmunoprecipitated from theseliferative actions, we searched for interacting proteins
cells using an anti-METS antibody (Figure 4D).using a GAL4-based yeast two-hybrid screen. Among
To determine whether DP103 was a corepressor re-1106 cotransformants, three independent clones were
quired for function of METS RD-N, nuclear microinjec-isolated encoding the C terminus of a protein that bound
tion experiments were performed in Rat 1 cells. Consis-METS with high affinity and specificity. A quantitative
tent with the specific binding of DP103 to RD-N of METS,yeast two-hybrid assay using one of these clones
microinjection of purified anti-DP103 IgG abolished the(Y-123) indicated specific interactions with regions of
repressor activity of this METS domain, but had no effectMETS encompassing RD-N, but not with RD-C (Figure
on repression by the C-terminal domain (Figure 4E). Mi-4A). The specificity of these interactions was confirmed
in vitro by GST pull-down experiments (Figure 4B). Se- croinjection of anti-Sin 3A/B IgG also selectively blocked
Combinatorial Control of Terminal Growth Arrest
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Figure 5. DP103 Exhibits Intrinsic Repres-
sor Activity Dependent on Interactions with
Sin3A/B, NCoR, and HDACs 2 and 5
(A) Mapping of the repressor activity of DP103
to the C terminus in a GAL-based transient
transfection assay in CV-1 cells.
(B) In vitro translated SMRT, NCoR, Sin3A, and
HDAC2 interact directly with GST fused to the
C-terminal repression domain of DP103, but
not the N-terminal DEAD box domain.
(C) DP103 repressor activity is abolished
by microinjection of antibodies specific for
N-CoR, SMRT, Sin3A/B, and histone deacet-
ylases (HDACs) 2 and 5. Expression plasmids
for GAL4 DNA binding domain alone or GAL4-
DP103 were microinjected into the nuclei of
quiescent Rat 1 fibroblasts along with the in-
dicated antibodies and tested for their effects
on the activity of the 5x-Tk-LacZ reporter.
(D) DP103 interacts with HDACs 2 and 5 in cells.
Whole-cell extracts of E2A-Pbx1-immortalized
bone marrow precursors overexpressing METS
were immunoprecipitated with preimmune
guinea pig serum or anti-DP103 antibodies.
The immunoprecipitates were subsequently
analyzed for HDAC2 and HDAC5 by Western
blot using specific antibodies.
repression by RD-N, suggesting an additional involve- in ChIP experiments. In concert, these findings suggest
that DP103 serves as an adaptor protein that nucleatesment of Sin3 corepressor complexes.
When linked to the GAL4 DNA binding domain, DP103 the assembly of a novel corepressor complex required
for function of METS RD-N.exhibited intrinsic repressor activity on the UAS-TK (Fig-
ure 5A). This activity was mediated by the unique To determine whether DP103 was required for METS-
mediated inhibition of DNA synthesis, microinjection ex-C-terminal domain of DP103, which was found to inter-
act with METS, N-CoR, Sin3A, and histone deacetylase periments were performed in Rat 1 fibroblasts using re-
combinant GST-METS and affinity-purified anti-DP1032 (HDAC-2) in GST pull-down assays (Figure 5B). To
test the functional importance of these interactions, the IgG. Microinjection of this IgG reversed the inhibitory
effects of METS on EGF-dependent incorporation ofeffects of nuclear microinjection of specific antibodies
on the transferable repression activity of DP103 were BrdU (Figure 6A). In the presence of anti-DP103 anti-
body, the antiproliferative effect of METS could be re-evaluated in Rat 1 cells using the GAL4 system. Microin-
jection of affinity-purified antibodies specific for N-CoR, stored by injecting recombinant GST-DP103 that con-
tains the C-terminal repressor domain. In contrast, anSMRT, Sin3A/B, HDAC-2, and HDAC-5 abolished or sig-
nificantly reduced repression activity (Figure 5C). In N-terminal fragment of DP103 containing only the RNA
helicase domains was ineffective in rescuing the METS-agreement with these findings, HDAC-2 and HDAC-5
were coimmunoprecipitated from whole-cell extracts of mediated cell cycle arrest (Figure 6A). Hence, the DP103
repressor domain was required for the METS-dependentE2A-Pbx1-immortalized bone marrow progenitor cells
using a DP103-specific antibody (Figure 5D). These find- block of cell proliferation.
ings are also consistent with the ability to detect METS,
HDAC2, and HDAC5 bound to the c-Myc promoter in Antiproliferative Effects of METS Require
pRb Family Proteinsterminally differentiated macrophages (Figure 3G). We
have as yet been unable to localize DP103 itself to the To investigate whether METS can induce cell cycle ar-
rest independently of pRb family proteins and E2F tran-c-Myc promoter by ChIP assay. However, available anti-
DP103 antibodies are directed against the identical do- scription factors, microinjection experiments were per-
formed in murine embryonic fibroblasts (MEFs) lackingmains required for interaction with other corepressor
components (data not shown). Therefore, these epitopes pRb, p107, and p130 (TKO MEFs; Sage et al., 2000).
Wild-type and mutant MEFs were cultured in serum-freedo not appear to be available for antibody recognition
Cell
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Figure 6. DP103 and the pRb Family Proteins
Are Required for METS-Dependent Inhibition
of DNA Synthesis
(A) Nuclei of Rat 1 cells were injected with
GST-METS and affinity-purified IgGs directed
against DP103, NcoR, and SMRT as indi-
cated. Cells were treated with EGF to stimu-
late DNA synthesis as shown in Figure 2E.
Anti- DP103 IgG abolished METS-mediated
inhibition of EGF-stimulated cell proliferation.
Effects of anti-DP103 IgG could be reversed
by coinjection for GST-DP103, but not by
coinjection of GST-DP103-N3.
(B) MEFs with the indicated genotypes were
injected with GST-METS and treated with
EGF to stimulate DNA synthesis. MEFs lack-
ing pRb, p107, and p130 exhibited a high rate
of BrdU incorporation regardless of the pres-
ence of EGF that was not sensitive to inhibi-
tion by METS.
(C) MEFs with the indicated genotypes were
injected with the UAS-TK-lacZ reporter gene
and expression plasmids for GAL4, GAL4-
METS, or GAL4-DP103.
(D) Effect of microinjection of calibrated
amounts of GST-METS on expression of a
c-Myc-lacZ reporter gene in wild-type MEFS
(WT-MEFs) and MEFs lacking Rb, p107, and
p105 (TKO cells).
(E) Chromatin immunoprecipitation assays
assessing occupancy of the c-Myc, Cdc2,
and p54 promoters by Ets 1 and/or Ets2
(Ets1/2), E2F1, E2F4, p107, or p130 in asyn-
chronous bone marrow progenitor cells (left)
or terminally differentiated peritoneal macro-
phages. C-Myc 3 represents a region 3 of
the c-Myc coding exons.
(F) Western blot analysis of p130 expression
in peritoneal macrophages and macrophages
derived from bone marrow progenitor cells in
the presence of M-CSF; 100 	g of total cellu-
lar protein was run in each lane.
conditions for 24 hr, microinjected with GST or GST- repressor activity on the UAS-TK-lacZ promoter in TKO
MEFs (Figure 6C). An alternative explanation is that theMETS, and treated with EGF as illustrated in Figure 6B.
Wild-type MEFs exhibited EGF-dependent DNA synthe- METS/DP103 complex functions in a combinatorial man-
ner with E2Fs and the pRb-related proteins to represssis that was blocked by METS, similar to results obtained
in Rat 1 fibroblasts. In contrast, TKO MEFs lacking all cell cycle control genes. To investigate this possibility,
the ability of calibrated amounts of microinjected METSthree proteins of the Rb gene family exhibited a high
rate of BrdU incorporation in the presence or absence of protein to repress transcription of the c-Myc promoter
in wild-type MEFs and TKO MEFs was evaluated (FigureEGF, and this incorporation was not inhibited by METS
(Figure 6B). These findings indicate that METS cannot 6D). In wild-type MEFs, c-Myc promoter activity was
markedly induced by serum treatment, and this activityinhibit DNA synthesis independently of the pRb family
members. One possible explanation is that pRb, p107, was completely inhibited by coinjection of physiologic
concentrations of GST-METS protein. In contrast, theand/or p130 are required for the intrinsic repression ac-
tivity of METS. This does not appear to be the case, c-Myc promoter was highly expressed in TKO MEFs in
the presence or absence of serum, and concentrationshowever, as GAL-METS and GAL-DP103 retained full
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Figure 7. Model for Mechanism by which In-
duction of METS and Its Association with
DP103 Functions to Selectively Inhibit Ras-
Dependent Cell Proliferation
(A) Temporal sequence of events in macro-
phage progenitor cells treated with M-CSF.
Induction of METS correlates with maximal
induction of SR-A and cell cycle arrest.
(B) During terminal differentiation, METS
selectively replaces Ets activators on cell cy-
cle control genes and cooperates with E2F/
p130 complexes to permanently silence tran-
scription.
of GST-METS that fully repressed the c-Myc promoter and analysis of its DNA binding specificity in vitro and
in vivo suggest a general mechanism for how METSin wild-type MEFs were nearly inactive in TKO MEFs.
To further investigate cooperation between METS and inhibits Ras signals required for proliferation, but not
differentiation (Figure 7B). We propose that a set of Etsthe Rb-related pocket proteins, ChIP experiments were
performed in bone marrow progenitor cells and termi- activators (e.g., Ets1, Ets2, and PEA3) that are respon-
sive to Ras signaling and promote both proliferation andnally differentiated macrophages (Figure 6E). In unsyn-
chronized bone marrow progenitor cells, Ets1/2 and differentiation programs bind to two distinct classes of
DNA recognition elements in target genes. One class ofE2F1 were observed to occupy the c-Myc, Cdc2, and p54
promoters, with E2F4 also being detected on the c-Myc DNA binding sites, found in cell type-specific genes such
as SR-A, consists of composite elements that are recog-and Cdc2 promoters. While the pattern of E2F1 and E2F4
binding was similar to that reported in unsynchronized nized by AP-1/Ets ternary complexes. The second class
of recognition elements, present in target genes suchT98G cells (Takahashi, et al., 2000), p107 and p130 were
not identified on E2F target genes in the progenitor cell as c-Myc, c-Myb, Cdc2, and the p54 subunit of DNA
primase that control cell cycle progression, are pro-population. METS was also not detected, consistent
with its lack of expression in these cells. In terminally posed to be recognized by Ets monomers. While METS
is capable of binding to the same monomer consensusdifferentiated macrophages, neither Ets1/2 nor E2F1
were detected on the c-Myc, Cdc2, and p54 promoters. sequence recognized by Ets activators, it appears to be
unable to form high-affinity ternary complexes requiredIn contrast, METS, p107, and p130 were now detected
on the c-Myc promoter in terminally differentiated mac- for activation of many cell type-specific genes. Thus,
induction of METS expression results in selective dis-rophages, and METS and p130 were detected on the
Cdc2 and p54 promoters. Intriguingly, Western blotting placement of Ets activators from monomeric binding
sites on cell cycle control genes, thereby inducing cellexperiments indicated that p130 was not detectable in
bone marrow progenitor cells, but was induced follow- cycle arrest without inhibiting Ras-dependent expres-
sion of cell type-specific genes (Figure 7B). A criticaling 7–9 days of M-CSF-dependent macrophage differ-
entiation (Figure 6F), coincident with induction of METS test of the ability of METS to discriminate between mo-
nomeric sites in cell cycle-regulatory genes and com-(Figure 1E).
posite elements in cell type-specific genes was provided
by ChIP assays, which clearly established selectiveDiscussion
binding of METS to Ets sites in the c-Myc, Cdc2, and
p54 promoters, but not to the composite AP-1/Ets siteDissociation of Ras-Dependent Proliferation
and Differentiation Programs by METS in the SR-A promoter in terminally differentiated macro-
phages. In contrast, Ets2 binding was observed on theIn this manuscript, we present evidence for a novel
mechanism linking terminal differentiation to cell cycle SR-A promoter, but not the c-Myc, Cdc2, or p54 promot-
ers in these same cells. A recent report presented evi-arrest that is based on the induction of the Ets repressor
METS/PE1. METS is expressed at low levels in macro- dence that METS/PE1 can inhibit expression of the
AP-1/Ets responsive MMP1 gene by a DNA binding-phage progenitor cells and is maximally induced in ter-
minally differentiated macrophages (Figure 7A). Retrovi- independent mechanism in an osteoblast cell line (Bidder
et al., 2000). This activity of METS/PE1 is not apparent inral-mediated expression or microinjection of physiologic
levels of METS protein blocked growth factor-dependent the primary macrophages or macrophage cell lines used
in these studies, as AP-1/Ets-responsive genes such asDNA synthesis and inhibited expression of the endoge-
nous c-Myc gene. Identification of METS target genes SR-A, MMP9, and macrosialin were maximally induced
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coincident with maximum expression of METS/PE1 (Fig- a model in which functional interactions between cell
type-specific transcriptional repressors, such as METS,ures 1 and 2).
Although the mechanisms that regulate METS expres- and E2F/pRB family protein complexes can provide a
mechanism for terminating proliferative responses tosion remain to be defined, it is interesting to note that
the sequence of the METS promoter itself contains two growth signals during development and thus ensure per-
manent exit from the cell cycle. In view of the criticalcomposite AP-1/Ets elements within 150 bp of the tran-
scriptional start site (D.S.-V. and C.K.G., unpublished importance of coordinating cell growth and differentia-
tion and the redundancy of function of Ets activators,data). The progressive increase in the expression and
activities of Ets2, c-Jun, and c-Fos that occurs during E2F transcription factors, and Rb-related pocket pro-
teins, it is likely that additional Ets repressors will proveterminal macrophage differentiation (e.g., Figure 2A)
may therefore not only drive the expression of genes to contribute to this combinatorial mechanism of growth
arrest.such as SR-A, but may also serve as a timing mechanism
for permanent exit from the cell cycle (Figure 7B) by
Experimental Proceduresinducing the expression of METS.
Cells and Transient Transfection Assays
METS Recruits a Novel Corepressor Complex CV-1 and 293T cells, Rat 1 fibroblasts, and pRB family TKO MEFs
Required for Inhibition of Cell Proliferation were maintained in DMEM with 10% fetal calf serum (FCS) and
While factors required for function of the C-terminal re- 1 penicillin-streptomycin (Pen/Strep). Primary murine progenitors
were isolated from the femurs and tibias of BALB/c mice and sepa-pression domain of METS remain to be defined, the
rated from mature phagocytotic and lymphocytic cells on Ficoll-N-terminal repressor domain of METS that conferred
Paque gradients. Differentiation was induced by culture in RPMIantiproliferative effects required interaction with DP103.
with 20% FCS and 1 Pen/Strep supplemented with M-CSF (10
DP103 appears to nucleate the assembly of a complex ng/ml). Culture and differentiation of Hoxa9-immortalized myeloid
consisting of components that are widely used by many progenitor cells, EcoM1-G, and EcoM1-M myeloid progenitor cells
other transcriptional repressors, although the specific was performed as described in Calvo et al. (2000) and Sykes and
Kamps (2001). CV-1 and 293T cells were transfected with lipofec-composition of a complex involving both HDAC2 and
tamine (Life Technologies) and analyzed as previously describedHDAC5 has not been reported previously. DP103 has
(Moulton et al., 1994).been independently identified as Gemin3, a component
of the survival of motor neurons (SMN) complex, in which
Antibodies
the putative RNA helicase activity is implicated in the Anti-METS and anti-DP103 IgGs were raised in guinea pigs using
building and recycling of spliceosomes (Charroux et al., purified, recombinant proteins corresponding to METS amino acids
1999, 2000). It has also been described as a regulator of 391–513 and DP103 amino acids 590–824, respectively. The follow-
ing antibodies were supplied by Santa Cruz Biotechnologies: anti-Polthe steroidogenic factor-1 (Ou et al., 2001). The present
II (#sc-900), anti-Ets2 (#sc-351), anti-HDAC-1 (#sc-7872), anti-HDAC2studies indicate that DP103 is a bifunctional protein,
(#sc-6296), anti-HDAC-3 (#sc-8138), anti-HDAC-5 (#sc-5252), anti-containing independent RNA processing and corepres-
HDAC-6 (#sc-5258), anti-mSin3A (#sc-767), anti-mSin3B (#sc-768),
sor functions. The observation that the C-terminal re- anti-E2F1 (#sc-193), anti-E2F4 (#sc-866), anti-p107 (#sc-193), anti-
pression domain of DP103 has been found to interact p130 (#sc-317), and anti-RbAp46 (#sc-8273).
with EBNA2 and EBNA3C is of particular interest with
Cloning of METS cDNAsrespect to the putative function of the METS/DP103
Reverse transcriptase polymerase chain reaction (RT-PCR) was car-complex in inhibition of cellular proliferation. EBNA2 and
ried out using total RNA from THP-1 monocytic leukemia cells asEBNA3C are synthesized by the Epstein-Barr virus dur-
the template along with the degenerate primers 5-[ATC] [AC]ing infection of B-lymphocytes and are essential for viral
[GATC] [CT] T [GATC] TGG [GC] A [GA] TT [TC] [TC] T [GATC] [CT]
transformation, but the mechanisms responsible for T-3 (sense) and 5-[CG] [GATC] [GATC] A [GAT] [GATC] [GT] T
their transforming properties remain poorly understood. [GATC] [GC] [GA] TA [GATC] [GT] TCAT-3 (antisense) correspond-
ing to highly conserved regions of the ets DBD. The PCR productThe present studies suggest the possibility that interac-
obtained for METS was used to screen a murine macrophage cDNAtions of EBNA2 and EBNA3C with DP103 interfere with
library, resulting in isolation of two independent full-length clones.the formation and/or function of the METS/DP103 com-
A splicing variant of METS, encoding the N-terminal 135 amino acidsplex, contributing to the transforming activities of the
and 8 unique C-terminal amino acids, was derived from two clones
Epstein-Barr virus. of a human adenocarcinoma cDNA library (IMAGE #1473929 and
1560232).
A Combinatorial Code for Cell Cycle Arrest
Cloning of DP103 cDNAsInvolving Ets and E2F Corepressor Complexes
A GAL4-based yeast two-hybrid screen of a human HeLaS3 cDNAThe observation that METS is unable to block DNA syn-
library (Clontech) was performed by cotransforming expression vec-thesis or completely repress the c-Myc promoter in cells
tors encoding METS_131-513 tethered to the GAL4-DBD (bait) and
lacking Rb, p107, and p130, but that it retains intrinsic library cDNAs linked to the GAL4-AD coding sequence (prey) into
repressive activity points to a combinatorial code of the yeast strain Y190. Three independent clones were obtained that
METS/DP103 and E2F/Rb-related signals for physio- encoded the C-terminal end of DP103, whose full-length sequence
was obtained by secondary screening of a human liver cDNA logic repression of cell cycle control genes (Figure 7B).
phage library.Combinatorial interactions between multiple repressors
have been shown to be required for appropriate cell-
DNA Binding Assaysspecific restriction of zen expression in the Drosophila
EMSA assays were performed as described previously (Moulton et
embryo (Jiang et al., 1993; Kirov et al., 1993) and growth al., 1994). The sequence of the double-stranded oligonucleotides
hormone gene expression in the anterior pituitary of with core Ets binding motifs underlined was as follows: 5-GATCCTA
CACAGGATGTCCATATTAGGACAGATC-3 (c-fos SRE), 5-GATCAAmice (Scully et al., 2000). The present studies suggest
Combinatorial Control of Terminal Growth Arrest
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GAAAGGAAATGACACATTCCTGGATC-3 (SRA promoter AP-1/Ets), Protein-Protein Interaction Assays
Coimmunoprecipitations were carried out in whole-cell extracts5-GATCTTGGCCGGAAGTGAGTCATTCGTATTTTGGATC-3 (con-
sensus Ets2). from extracts E2A-Pbx1-immortalized bone marrow progenitor cells
using specific guinea pig antisera raised against DP103_590-824
and METS_391-513. GST protein-protein interaction assays were car-
Chromatin Immunoprecipitation Assays ried out as described previously (Jepsen et al., 2000); DP103_590-
Cells were fixed with 1% formaldehyde and treated as previously 824, full-length METS, N-CoR_1586-2453, full-length Sin3A, and full-
described (Hecht and Grunstein, 1999). Recovered cross linked ad- length HDAC2 were translated in vitro using 35S-labeled methionine
ducts were sheared by sonication, resulting in an average length of and rabbit reticulocyte lysates (Promega).
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